Announcement • Jun 13
Cheelcare Inc. announced that it expects to receive CAD 1.5 million in funding Cheelcare Inc. announced a non brokered private placement for the issuance 1,000,000 units at an issue price of CAD 1.5 for the proceeds of CAD 1,500,000 on June 11, 2026. Each Unit consists of one common share and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Share of the Company at price of CAD 2.25 per Share for a period of two years from the date of closing. The Warrants are subject to an acceleration clause whereby, if at any time prior to the expiry of the Warrants, the closing price of the Shares on the TSX Venture Exchange equals or exceeds CAD 3.00 for any 10 consecutive trading days, the Company may, at its option, accelerate the expiry date of the Warrants to the date that is 30 days after the Company provides notice of announcing such acceleration. Any Warrants remaining unexercised after the accelerated expiry date will automatically expire, and all rights of the holders of such Warrants will terminate without compensation. Completion of the Offering is subject to the acceptance of the TSX Venture Exchange (the "Exchange) and other customary closing conditions. The Units, and all securities underlying the Units, will be subject to a statutory hold period of four months and one day from their date of issue in accordance with applicable securities laws. Reported Earnings • Mar 26
Third quarter 2026 earnings released: CA$0.018 loss per share (vs CA$0.039 loss in 3Q 2025) Third quarter 2026 results: CA$0.018 loss per share. Revenue: CA$470.6k (up 19% from 3Q 2025). Net loss: CA$509.8k (loss widened 64% from 3Q 2025). Announcement • Feb 18
Cheelcare Inc. announced that it has received CAD 1 million in funding On February 18, 2026, the company closed the transaction. 
